Medical Technology Company


We are experienced professionals in the medical trade that invest in, innovate on, custom build and develop medical technology assets for strategic transfers to larger firms who can more efficiently commercialize with scale.  

Current investments focus around platform technologies for implantable biomedical systems. One of our prized investments are the pacemaker technology assets acquired – and further developed – to enable the production of Active Implantable Medical Devices (AIMD), a niche burgeoning $16B+ industry vertical.

Pacemaker Product Technology

The firm setup independent manufacturing operations in 2008 in Bangalore, India. Through this technology over 40,000 implantable cardiac pacemaker systems have been produced and distributed over the past three decades across Latin America, The Indian sub-continent, Asia, The GCC and MENA region, Greek & Balkan States, Eastern Europe and other such CE accepting nations. The CRM product is well positioned to be the ‘value segment’ leader across the emerging markets. 

Per WHO Cardiac Arrhythmia is the single largest therapeutic area which remains undeserved across all emerging markets. The Cardiac Rhythm Management (CRM) technology developed is well designed and positioned to serve this burgeon market need. 

The products meet the highest industry standard’s of Quality and Regulatory approvals – the products are CE [European Standard] Certified by BSI, the Quality Systems are ISO 13485-9001 Compliant and Certified to Class III Grade Regulatory Standards. The system complies with FDA Standards for both export only and domestic distribution. 

AIMD Process Technology 

The original technology provider, CCC del Uruguay (Now part of Integer Medical) holds the Gold Standard in the Intellectual Property for the design, development and production of AIMD systems. Under a Transfer of Technology with CCC in 2007, the Intellectual Property to enable independent manufacturing of Class III Active Implantable Medical Device (AIMD) systems was licensed, along with custom fabricated capital equipment assets. 

The firm today is empowered with unrestricted global rights to further innovate on, manufacture and distribute active implantable device systems including Pacemaker IPG’s, pacing lead electrodes, RF enabled wireless handheld programmers and ECG communication systems and all the necessary parts, sub-assemblies and accessories for such systems;  Today we remain the ONLY other known Company in the world, apart from Integer (post the GreatBatch Medical acquisition) to own the Intellectual Property Rights to this technology. 

With a strategic partnership in 2019 with California Medical Labs based in Orange County, CA we bring this established technology under license to North America. Through this we seek to further empower established North American Medical Device Manufacturing and Development Companies to service the burgeon Class III implantable medical devices industry with providing the technical know-how to build and manufacture the AIMD Box used across most implantable bio-electronic system applications. 

Relevant parties may establish contact at:


Video On Pacemaker Production 


The link showcases a virtual tour of the pacemaker manufacturing plant setup under Technology Transfer protocol.